Shantanu Gupta
Universidade Federal do Rio Grande do Norte, Universidade de São Paulo, Singhania University
About
Dr. Shantanu Gupta is a bioinformatician and computational systems biologist specializing in cancer regulatory networks, non-coding RNA (ncRNA) mechanisms, and cell death pathways.
He earned his Bachelor’s degree in Bioinformatics from Singhania University, India (2011), ranking among the top five students in his class. He then pursued advanced studies in Brazil, completing a Master’s in Physics (2016) at the Federal University of Santa Maria (UFSM), RS, Santa Maria. He continued directly in the same department, receiving his Ph.D. in Physics (2021). His doctoral research focused on systems biology and dynamic computational modeling of signaling and ncRNA-mediated gene regulatory networks in cancer.
During his Ph.D., he published multiple peer-reviewed studies, including early and influential work on autophagy in cancer biology. He has since served as a peer reviewer for over 100 high-impact international journals, including Molecular Cancer, contributing to interdisciplinary advancements in computational oncology. From September 2021 to October 2023, he held his first postdoctoral fellowship in Mathematics and Statistics at the Department of Computer Science, University of São Paulo (IME-USP), São Paulo, where he integrated systems biology with AI-driven computational modeling to investigate complex biological networks. His second postdoctoral fellowship (April 2024 – January 2025) at the same institution deepened this line of research, focusing on ncRNA-mediated control of cell death modalities (apoptosis, autophagy, ferroptosis) and their roles in cancer progression and therapeutic resistance. Notably, he contributed one of the earliest computational studies on ferroptosis regulation in oncology.
Since August 2025, Dr. Gupta has been a Visiting Associate Professor in the Bioinformatics Multidisciplinary Environment (BioME)-IMD program at the Federal University of Rio Grande do Norte (UFRN), Natal, where he teaches bioinformatics and computational systems biology while leading research on network modeling and AI applications in biomedical systems. He currently serves as an Academic Editor for PLOS Computational Biology, BMC Bioinformatics, PLOS ONE, and Discover Oncology. His research integrates systems biology, network theory, bioinformatics, and artificial intelligence to elucidate mechanistic underpinnings of cancer dynamics, with particular emphasis on ncRNA regulation and cell death decisions in therapeutic resistance.
Employment
-
Universidade Federal do Rio Grande do Norte Visiting Associate Professor2025 - Present
Education
-
Universidade de São Paulo Postdoc2024 - 2025
-
Universidade de São Paulo Postdoc2021 - 2023
-
Singhania University B.Tech Bioinformatics2007 - 2011
Projects & Funding
Projects & funding information is unavailable.
Publications (28)
- miR-206 orchestrates breast cancer radiosensitivity through a SIRT1/p53 feedback loop: a network medicine modelling study Save
- An ATM–AMPK–Wip1 feedback loop governing DNA-damage signaling and tumor stress responses Save
- p53 Orchestrates the Immunogenic-Tolerogenic Pyroptosis Switch in Non-Small Cell Lung Cancer: A Systems Biology Approach Save
- Systems biology approach reveals the dynamics of cancer stem cell acquisition in ewing sarcoma: the role of let-7 and miR-145 regulatory circuits Save
- The p21 resilience network: a conceptual framework linking senescence to ferroptosis and cuproptosis resistance Save
- Systems biology of gene regulation: qualitative simulation with Boolean networks Save
- DNA Damage-Induced Ferroptosis: A Boolean Model Regulating p53 and Non-Coding RNAs in Drug Resistance Save
- Targeting NSCLC drug resistance: Systems biology insights into the MALAT1/miR-145-5p axis and Wip1 in regulating ferroptosis and apoptosis Save
- LncRNA PTENP1/miR-21/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response Save
- A dynamic Boolean network reveals that the BMI1 and MALAT1 axis is associated with drug resistance by limiting miR-145-5p in non-small cell lung cancer Save